Non-steroidal mineralocorticoid receptor antagonists in heart failure

Novel non-steroidal mineralocorticoid receptor antagonists (MRAs) have improved pharmacological properties compared with steroidal MRAs. Among the non-steroidal MRAs, finerenone has been approved for patients with chronic kidney disease who have diabetes mellitus and has demonstrated favourable safe...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Nature reviews cardiology 2023-10, Vol.20 (10), p.645-646
Hauptverfasser:	Filippatos, Gerasimos, Farmakis, Dimitrios
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/75/230 692/700/565/1436 Cardiac Imaging Cardiac Surgery Cardiology Clinical Outlook Diabetes Ejection fraction Enzymes Heart failure Hospitalization Hyperkalemia Kidney diseases Medicine Medicine & Public Health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!